Skip to main content

Table 4 Risk estimation for NAFLD in association with pre-existing co-morbid conditions

From: Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal

  NAFLD Control X2 RR p
Diabetes (FBS ≥ 126 mg/dl) (n) (n)    
 Yes 36 9 5.621 1.68 0.016
 No 183 201    
Cardiovascular Risk (TC/HDL-C > 5)
 Yes 135 9 52.721 3.18 < 0.001
 No 84 201    
Hyperurecemia (UA > 7.5 mg/dl)
 Yes 33 15 2.259 1.41 0.107
 No 186 195    
Central Obesity (WC > 94 cm(M),> 80 cm(F))
 Yes 123 24 34.909 2.50 < 0.001
 No 96 186    
  1. Bold represents statistically significant values (p < 0.05). RR- relative risk, n- the number of population